Matthew W. McClure - Chief Medical Officer at Aligos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
ALGS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew W. McClure since 12/17/2023

Holdings reported by Matthew W. McClure for Aligos Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 72K Mar 1, 2024 Direct Common Stock

Transactions reported by Matthew W. McClure for Aligos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.